MannKind Corp reports results for the quarter ended June 30 - Earnings Summary

• MannKind Corp MNKD.OQ reported quarterly breakeven results​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -1 cents. The mean expectation of eight analysts for the quarter was for earnings of 5 cents per share. Wall Street expected results to range from 4 cents to 6 cents per share.

• Revenue rose 5.7% to $76.53 million from a year ago; analysts expected $78.60 million.

• MannKind Corp's reported EPS for the quarter was breakeven results​.

• The company reported quarterly net income of $668 thousand.

• MannKind Corp shares had risen by 6.7% this quarter and lost 37.9% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 12.2% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for MannKind Corp is $9.00, about 55.7% above its last closing price of $3.99

This summary was machine generated from LSEG data August 6 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)